ResMed Inc. (RMD) |
218.99 3.04 (1.41%)
|
03-31 16:00 |
Open: |
217.23 |
Pre. Close: |
215.95 |
High:
|
219.52 |
Low:
|
217.17 |
Volume:
|
471,659 |
Market Cap:
|
32,172(M) |
|
|
Technical analysis |
as of: 2023-03-31 4:21:45 PM |
Overall:
|
|
Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
Target: |
Six months: 257.74 One year: 301.04 |
Support: |
Support1: 210.5 Support2: 204.22 |
Resistance: |
Resistance1: 220.66 Resistance2: 257.74 |
Pivot: |
211.8  |
Moving Average: |
MA(5): 215.46 MA(20): 212.19 
MA(100): 217.72 MA(250): 218.78  |
MACD: |
MACD(12,26): 0.1 Signal(9): -1  |
Stochastic oscillator: |
%K(14,3): 86.2 %D(3): 78.2  |
RSI: |
RSI(14): 58.4  |
52-week: |
High: 253.66 Low: 189.39 |
Average Vol(K): |
3-Month: 627 (K) 10-Days: 431 (K) |
|
Price, moving averages and Bollinger Bands |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ RMD ] has closed Bollinger Bands are 33.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
219.78 - 220.63 |
220.63 - 221.47 |
Low:
|
214.91 - 215.94 |
215.94 - 216.97 |
Close:
|
217.32 - 218.89 |
218.89 - 220.45 |
|
Company Description |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. |
Headline News |
Fri, 31 Mar 2023 ResMed Inc. stock rises Friday, still underperforms market - MarketWatch
Fri, 31 Mar 2023 ResMed Inc. (NYSE:RMD) Given Average Rating of "Moderate Buy ... - MarketBeat
Thu, 30 Mar 2023 2023-03-30 | NYSE:RMD | Press Release | ResMed Inc. - Stockhouse
Fri, 24 Mar 2023 Congress Asset Management Co. MA Lowers Stake in ResMed Inc ... - MarketBeat
Wed, 22 Mar 2023 LVZ Inc. Takes $334000 Position in ResMed Inc. (NYSE:RMD) - MarketBeat
Thu, 16 Mar 2023 Reasons Why You Should Retain ResMed (RMD) Stock For Now - Nasdaq
|
Financial Analysis |
Price to Book Value: |
Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Price to Earnings: |
Outperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Discounted cash flow: |
Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Return on Assets: |
Neutral |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Return on Equity: |
Neutral |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Debt to Equity: |
Outperform |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: NYSE |
Sector: Healthcare |
Industry: Medical Instruments & Supplies |
Shares Out. |
147 (M) |
Shares Float |
146 (M) |
% Held by Insiders
|
1.2 (%) |
% Held by Institutions
|
66.4 (%) |
Shares Short
|
1,080 (K) |
Shares Short P.Month
|
845 (K) |
Stock Financials |
EPS
|
5.46 |
EPS Est Next Qtl
|
0.75 |
EPS Est This Year
|
3.05 |
EPS Est Next Year
|
3.4 |
Book Value (p.s.)
|
25.45 |
Profit Margin (%)
|
21.5 |
Operating Margin (%)
|
28 |
Return on Assets (ttm)
|
11.5 |
Return on Equity (ttm)
|
23.5 |
Qtrly Rev. Growth
|
15.5 |
Gross Profit (p.s.)
|
14.02 |
Sales Per Share
|
25.59 |
EBITDA (p.s.)
|
8.03 |
Qtrly Earnings Growth
|
11.6 |
Operating Cash Flow
|
370 (M) |
Levered Free Cash Flow
|
124 (M) |
Stock Valuations |
PE Ratio
|
40.03 |
PEG Ratio
|
3.2 |
Price to Book value
|
8.6 |
Price to Sales
|
8.55 |
Price to Cash Flow
|
86.89 |
Stock Dividends |
Dividend
|
0.43 |
Forward Dividend
|
0 |
Dividend Yield
|
0.2% |
Dividend Pay Date
|
2021-12-15 |
Ex-Dividend Date
|
2021-11-08 |
Your Ad Here
|
|